Csgalnact2tm1e(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Csgalnact2tm1e(KOMP)Wtsi |
Name: |
chondroitin sulfate N-acetylgalactosaminyltransferase 2; targeted mutation 1e, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4362134 |
Gene: |
Csgalnact2 Location: Chr6:118084413-118116101 bp, - strand Genetic Position: Chr6, 55.86 cM
|
IMPC: |
Csgalnact2 gene page |
|
Mutant Cell Lines: |
EPD0043_5_A02, EPD0043_5_B01, EPD0043_5_B02, EPD0043_5_B03, EPD0043_5_C01, EPD0043_5_C02, EPD0043_5_C03, EPD0043_5_D01, EPD0043_5_D02, EPD0043_5_E02, EPD0043_5_E03, EPD0043_5_F01, EPD0043_5_F03, EPD0043_5_G03, EPD0043_5_H02, EPD0043_5_H03 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8.F6 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutation: |
|
Insertion
Vector: L1L2_st0
|
|
|
Mutation details: The L1L2_st0 cassette was inserted at position 118107004 of Chromosome 6 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT flanked lacZ/neomycin sequence followed by a loxP site. Insertion of this cassette creates a reporter knockout mouse. Cre expression will remove the neomycin selection cassette. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|